Mark your calendars! RESILIENCE 2026, our upcoming international virtual conference on May 7-8, 2026, is set to elevate Multiple Chemical Sensitivity (MCS) as a defining public health and accessibility challenge. We're bringing together global experts to explore the latest science and its implications for healthcare, inclusive environments, and policy. Discover how we're shaping a more accessible future. Read the full release for more details.

Get ready for RESILIENCE 2026, our virtual international conference, May 7-8! We're diving deep into Multiple Chemical Sensitivity (MCS) as a critical public health and accessibility challenge. Day 1 will build a robust evidence base, exploring research, genetic factors, and the rising prevalence of MCS in Canada. Day 2 shifts to action, translating science into policy, legal frameworks, and healthcare solutions. Join a multi-sector panel to discuss inclusion, rights, and systemic reform for a better future. Discover more about this vital event.

Join us virtually for RESILIENCE 2026, May 7-8, 2026! This international conference shines a light on Multiple Chemical Sensitivity (MCS) as a critical public health and accessibility issue. We're gathering leading global researchers, clinicians, and policymakers to discuss the latest scientific evidence and its impact on healthcare and inclusive environments. This fully accessible event is a powerful step towards understanding and addressing MCS worldwide. Discover how we're shaping a more inclusive future for everyone. Dive into the details.

Join us for RESILIENCE 2026, a virtual conference on May 7-8, 2026, elevating Multiple Chemical Sensitivity (MCS) as a critical public health and accessibility issue. Discover cutting-edge research, explore policy solutions, and engage with leaders tackling chemical exposures and advocating for systemic reform. Learn more about this vital discussion.

RESILIENCE 2026 will put Multiple Chemical Sensitivity (MCS) in focus as a key public health and accessibility issue. Global experts gather virtually May 7-8, 2026, to discuss science, healthcare, and inclusive policy. Explore the full release!

RESILIENCE 2026, a pivotal virtual conference on May 7-8, 2026, will address Multiple Chemical Sensitivity (MCS) as a critical public health and accessibility issue. Day one explores the evidence base, from federal perspectives and emerging research to the rising prevalence of MCS in Canada. Day two shifts to actionable solutions, examining policy translation, legal frameworks, healthcare practices, and community strategies to improve quality of life. A multi-sector Civil Society Panel will further discussions on inclusion and systemic reform. Dive deeper into this important initiative.

RESILIENCE 2026 is set to redefine our understanding of Multiple Chemical Sensitivity (MCS)! This virtual international conference, May 7-8, 2026, will powerfully position MCS as a key challenge for public health, accessibility, and human rights. We are bringing together global experts to translate vital scientific knowledge into meaningful action and change. The Environmental Health Association of Canada is proud to lead this critical shift. Registration is free and open to all. Learn more about this groundbreaking event and how it impacts our future.

RESILIENCE 2026 is on the horizon! Join us virtually May 7-8, 2026, as global experts convene to elevate Multiple Chemical Sensitivity (MCS) as a pivotal public health and accessibility issue. This international conference will explore crucial scientific evidence and policy implications for a more inclusive future. Learn more about this important initiative.